Financials Kovo HealthTech Corporation
Equities
KOVO
CA50073R1073
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | +16.67% | +16.67% | +16.67% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 11.11 | 3.524 | 1.302 |
Enterprise Value (EV) 1 | 15.29 | 7.96 | 7.21 |
P/E ratio | -3.73 x | -13.9 x | -0.25 x |
Yield | - | - | - |
Capitalization / Revenue | 1.88 x | 0.33 x | 0.13 x |
EV / Revenue | 2.59 x | 0.75 x | 0.72 x |
EV / EBITDA | -16.5 x | -9.28 x | -2.32 x |
EV / FCF | 33.9 x | -5.45 x | 28.6 x |
FCF Yield | 2.95% | -18.4% | 3.49% |
Price to Book | -65.6 x | 3.81 x | -4.36 x |
Nbr of stocks (in thousands) | 36,014 | 39,944 | 57,544 |
Reference price 2 | 0.3085 | 0.0882 | 0.0226 |
Announcement Date | 28/03/22 | 27/04/23 | 30/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 2.033 | 1.769 | 3.019 | 5.904 | 10.55 | 10.02 |
EBITDA 1 | 0.102 | 0.499 | -0.655 | -0.924 | -0.858 | -3.113 |
EBIT 1 | 0.087 | 0.347 | -0.884 | -1.259 | -1.101 | -3.524 |
Operating Margin | 4.28% | 19.62% | -29.28% | -21.32% | -10.44% | -35.19% |
Earnings before Tax (EBT) 1 | -0.199 | 0.009 | -1.199 | -2.7 | -0.913 | -4.721 |
Net income 1 | -0.199 | 0.009 | -1.199 | -2.7 | -0.25 | -4.684 |
Net margin | -9.79% | 0.51% | -39.72% | -45.73% | -2.37% | -46.77% |
EPS 2 | -0.0133 | 0.000600 | -0.0451 | -0.0827 | -0.006356 | -0.0900 |
Free Cash Flow 1 | -0.1 | 0.0788 | -0.1628 | 0.4514 | -1.461 | 0.2519 |
FCF margin | -4.92% | 4.45% | -5.39% | 7.65% | -13.85% | 2.51% |
FCF Conversion (EBITDA) | - | 15.78% | - | - | - | - |
FCF Conversion (Net income) | - | 875% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 02/12/20 | 02/12/20 | 27/05/21 | 28/03/22 | 27/04/23 | 30/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 2.06 | 1.94 | 2.32 | 4.18 | 4.44 | 5.91 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 20.23 x | 3.878 x | -3.539 x | -4.523 x | -5.17 x | -1.898 x |
Free Cash Flow 1 | -0.1 | 0.08 | -0.16 | 0.45 | -1.46 | 0.25 |
ROE (net income / shareholders' equity) | 9.66% | -0.43% | 90.5% | 689% | -66.3% | -1,499% |
ROA (Net income/ Total Assets) | 15.1% | 59.7% | -31.1% | -15% | -9.65% | -27.2% |
Assets 1 | -1.319 | 0.0151 | 3.855 | 18.05 | 2.592 | 17.22 |
Book Value Per Share 2 | -0.1400 | -0.1400 | -0.0200 | -0 | 0.0200 | -0.0100 |
Cash Flow per Share 2 | 0 | 0 | 0.0100 | 0.0200 | 0.0200 | 0 |
Capex | - | - | - | - | 0.09 | 0.04 |
Capex / Sales | - | - | - | - | 0.83% | 0.37% |
Announcement Date | 02/12/20 | 02/12/20 | 27/05/21 | 28/03/22 | 27/04/23 | 30/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+16.67% | 1.47M | |
-7.16% | 28.89B | |
+41.90% | 9.26B | |
+32.14% | 4.58B | |
-33.18% | 2.53B | |
-8.48% | 1.62B | |
-27.03% | 1.26B | |
-40.11% | 1.02B | |
+5.50% | 943M | |
-39.39% | 845M |
- Stock Market
- Equities
- KOVO Stock
- Financials Kovo HealthTech Corporation